Position in DHR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,303,665
-$325,518 QoQ
Shares Held
12,094
-12.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#843
of 2,105 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $7,174,733 across 11 Diagnostics & Research names. DHR ranks #1 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
12,094 | $2,303,665 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,977 | $991,188 | |
| 3 | LH |
Labcorp Holdings Inc.
|
2,603 | $728,840 | |
| 4 | NTRA |
Natera, Inc.
|
2,405 | $652,837 | |
| 5 | ILMN |
Illumina, Inc.
|
3,604 | $633,691 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
886 | $469,216 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,241 | $433,006 | |
| 8 | WAT |
Waters Corp /De/
|
1,042 | $390,791 |
All Filings in DHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,303,665 | 12,094 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,629,183 | 13,867 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,972,755 | 12,986 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,784,759 | 14,046 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,805,660 | 14,203 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,650,650 | 12,930 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,162,280 | 13,776 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,841,124 | 13,816 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,490,654 | 13,971 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $2,550,640 | 10,214 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,407,092 | 10,405 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,504,569 | 10,095 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,228,640 | 9,286 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,411,266 | 9,567 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,708,876 | 10,206 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,828,017 | 10,949 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,655,115 | 10,473 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $2,779,301 | 9,475 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,118,027 | 9,477 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,689,422 | 8,834 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,351,638 | 8,763 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,380,445 | 10,576 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,343,354 | 10,549 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,150,931 | 9,989 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $1,262,437 | 9,121 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||